DEA Aligns Regs With Labeling Rules for Products Containing Certain Steroids
The Drug Enforcement Administration is updating its regulations to better align with the Designer Anabolic Steroid Control Act of 2014, which added new labeling requirements for products containing anabolic steroids. The law’s labeling provision states that it’s illegal to import,…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
export, manufacture, distribute or dispense -- “or possess with intent to manufacture, distribute, or dispense” -- an anabolic steroid or product containing an anabolic steroid unless the product includes a label “clearly identifying the anabolic steroid or product containing an anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry.” DEA said it’s “simply updating its regulations to be consistent with the exact terms of DASCA.” The rule takes effect Aug. 1.